InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Meyers Michael L., Vice-Président Senior, Directeur Médical. Director active across 2 companies, notably Syndax Pharmaceuticals Inc. Aggregated, 6 disclosures have been published. Activity tracked since 30 December 2021. The latest transaction was disclosed on 15 July 2026 (U). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Meyers Michael L. is Senior Vice President, Chief Medical Officer. He is linked to Nuvalent, Inc. as Director and to Syndax Pharmaceuticals Inc as SVP, Chief Medical Officer, and his 6 filings cover recent filings from 2022-01-03 to 2026-07-15, with Attribution as the transaction nature in the sampled items.